WINNINGHAM RICK E (Chief Executive Officer) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/19/2024ACC: 0001415889-24-008630
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-4.30K
Net shares
Net seller
$23.4K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
6.60K acquired · 10.90K disposed
Non-Derivative Transactions4
Ordinary Shares
Direct
Shares
+2.70K
Price / share
$8.64
Trade value
$23.36K
% of position
0.2%
3/15/2024
1.56M→1.56M
Ordinary Shares
Direct
Shares
−7K
Price / share
—
Trade value
—
% of position
0.4%
3/15/2024
1.56M→1.55M
Ordinary Shares
Direct
Shares
−3.90K
Price / share
—
Trade value
—
% of position
0.3%
3/15/2024
1.55M→1.55M
Ordinary Shares
Indirect
Shares
+3.90K
Price / share
—
Trade value
—
% of position
New position
3/15/2024
0.00→3.90K
Total
Net shares
−4.30K
Net value
$23.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/15/2024 | A · Award | +2.70K | $8.64 | $23.36K | 0.2% | 1.56M | 1.56M |
| Ordinary Shares Direct | 3/15/2024 | G · Gift | −7K | — | — | 0.4% | 1.56M | 1.55M |
| Ordinary Shares Direct | 3/15/2024 | G · Gift | −3.90K | — | — | 0.3% | 1.55M | 1.55M |
| Ordinary Shares Indirect | 3/15/2024 | G · Gift | +3.90K | — | — | New position | 0.00 | 3.90K |
| Total | −4.30K | $23.36K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported